Successful Treatment of an Acute Exacerbation of Multiple Sclerosis by External Magnetic Fields

References

• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Chou C., Anton S., Wurtman R.J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Armstrong D.L., Hay M., Tenian D.M. Modulation of cerebellar granule cell activity by iontophoretic application of serotonergic agents. Brain Research Bulletin 1987; 19: 699–704
   PubMed Web of Science ®Google Scholar
• Bauer H.J. Problems of symptomatic therapy in multiple sclerosis. Neurology 1978; 28: 8–20
   PubMed Web of Science ®Google Scholar
• Bishop G.A., Ho R.H. The distribution and orgin of serotonin immunoreactivity in the rat cerebellum. Brain Research 1985; 331: 195–207
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I., Yahr M.D., Mylin L., Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Cardarelli N.F. The role of a thymus-pineal axis in an immune mechanism of aging. Journal of Theoretical Biology 1990; 145: 397–405
   Google Scholar
• Chakravorty B.G. Association of trigeminal neuralgia with multiple sclerosis. Archives of Neurology 1966; 14: 95–99
   PubMedGoogle Scholar
• Chiappa K.H., Harrison J.L., Brooks E.B., Young R.R. Brainstem auditory evoked responses in 200 patients with multiple sclerosis. Annals of Neurology 1980; 7: 135–143
   PubMed Web of Science ®Google Scholar
• Clark C.M., Fleming J.A., Li D., Oger J., Klonoff H., Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Archives of Neurology 1992; 49: 641–643
   PubMedGoogle Scholar
• Claveria L.E., Curzon G., Harrison M. J. G., Kantamaneni B.D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Clifford D.B., Trotter J.L. Pain in multiple sclerosis. Archives of Neurology 1984; 41: 1270–1272
   PubMedGoogle Scholar
• Davidson D., Pullar I.A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Freedman M.S., Gray T.A. Vascular headache: a presenting symptom of multiple sclerosis. Canadian Journal of Neurological Sciences 1989; 16: 63–66
   PubMed Web of Science ®Google Scholar
• Gilroy J., Meyer J.S. Medical neurology, 3rd Edition. Macmillan Publishing Co., Inc., New York 1979; 157
   Google Scholar
• Holder G.E., Bartlett J.R., Bridges P.K., Kantamanei B.D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Hughes R. A. C. Prospects for the treatment of multiple sclerosis. Journal of the Royal Society of Medicine. 1991; 84: 63–65
   PubMed Web of Science ®Google Scholar
• Hyyppa M.T., Jolma T., Riekkinen P., Rinne U.K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jensen T.S., Rasmussen P., Reske-Nelsen E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurologica Scandinavica 1982; 65: 182–189
   PubMed Web of Science ®Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Lennon V.A., Carnegie P.R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancer 1971; 2: 630–633
   Google Scholar
• Maestroni G. J. M., Pierpaoli W. Pharmacologic control of the hormonally mediated immune response. Psychoneuroimmunology, R. Ader. Academic Press., New York 1981; 405
   Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G.P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vo. 44: 277–279
   Google Scholar
• Matthews W. B. Paroxysmal symptoms in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1975; 38: 617–623
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S. Magnetic field effects on pineal gland melatonin synthesis: comparative studies on albino and pigmented rodents. Brain Research 1986; 369: 365–368
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Scierms 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience 1988; 39: 165–175
   PubMed Web of Science ®Google Scholar
• Poloni M., Nappi G., Arringo A., Savoldi F. Cerebrospinal fluid 5-hydroxyindoleacetic acid level in migrainous patients during spontaneous attacks, during headache-free periods and following treatment with L-tryptophan. Experientia 1974; 30: 640–641
   PubMedGoogle Scholar
• Relkin R., Schneck L. Effects of pinealectomy on rat brain myelin. Proceedings of the Society for Experimental Biology and Medicine 1975; 148: 337–338
   PubMed Web of Science ®Google Scholar
• Relkin R., Fok W.Y., Schneck L. Pinealectomy and brain myelination. Endocrinology 1973; 92: 1426–1428
   PubMed Web of Science ®Google Scholar
• Rella W., Lapin V. Immunocompetence of pinealectomized and simultaneously pinealectomized and thymectomized rats. Oncology 1976; 33: 3–6
   PubMed Web of Science ®Google Scholar
• Reuss S.T., Semm P., Vollrath L. Different types of magnetically sensitive cells in the rat pineal gland. Neuroscience Letters 1983; 40: 23–26
   PubMed Web of Science ®Google Scholar
• Rozencwaig R., Grad B.R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Rudick R.A. Helping patients live with multiple sclerosis. What primary care physicians can do. Postgraduate Medicine 1990; 88: 197–207
   PubMed Web of Science ®Google Scholar
• Rudick R.A., Schiffer R.B., Herndon R.M. Drug treatment of multiple sclerosis. Seminars in Neurology 1987; 7: 150–159
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal CAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Rushton J.G., Olafson R.A. Trigeminal neuralgia associated with multiple sclerosis. Archives of Neurology 1965; 13: 383–386
   PubMedGoogle Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. The influence of the pineal gland on migraine and cluster headaches and effects of treatment with pico Tesla magnetic fields. International Journal of Neuroscience, in press
   Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience, in press
   Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S.S. Campbell, R.J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Sergott R.C., Brown M.J., Silberberger D.H. Remyelination follows antibody-induced central nervous: system demyelination. Annals of Neurology 1986; 20: 94–98
   PubMed Web of Science ®Google Scholar
• Sicuteri F. Headache biochemistry and pharmacology. Archives of Neurobiology (Madrid) 1974; 37: 27–59
   PubMedGoogle Scholar
• Sicuteri F., Buffoni F., Anselmi B., Del Bianco P.L. An enzyme (MAO) defect on the platelets in migraine. Research in Clinical Studies of Headaches. Karger, Basel 1972; 3: 245–251
   Google Scholar
• Silberstein S.D. Advances in understanding the pathophysiology of headache. Neurology 1992; 42: 6–10, Suppl 2
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U.K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stockard J.J., Stockard J.E., Sharbrough F.W. Brainstem auditory evoked potentials in neurology: methodology, interpretation, clinical application. Electrodiagnosis in clinical neurology, M.J. Aminoff. Churchill Livingstone., New York 1980; 370–413
   Google Scholar
• Strahlendorf J.C., Barnes C.D. Modulation of cerebellar neuronal activity by raphe stimulation. Brain Research 1979; 169: 565–569
   PubMed Web of Science ®Google Scholar
• Strahlendorf J.C., Lee M., Strahlendorf H.K. Effects of serotonin on cerebellar Purkinje cells are dependent on the baseline firing rate. Experimental Brain Research 1984; 56: 50–58
   PubMed Web of Science ®Google Scholar
• Takeuchi Y., Kimura H., Sano Y. Immunohistochemical demonstration of serotonin-containing nerve fibres in the cerebellum. Cell Tissue Research 1982; 225: 2–12
   Google Scholar
• Toglia J.U. Is migraine due to a deficiency of pineal melatonin. Italian Journal of Neurological Sciences 1986; 7: 319–323
   PubMedGoogle Scholar
• Twomey J.A., Espir L.E. Paroxysmal symptoms as the first manifestation of multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1980; 43: 296–304
   PubMed Web of Science ®Google Scholar
• Watkins S.M., Espir M. Migraine and multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1969; 32: 35–37
   PubMed Web of Science ®Google Scholar
• Wetterberg L. Melatonin in humans physiological and clinical studies. Journal of Neural Transmission 1978; 13 (suppl): 289–310
   Google Scholar